Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hyper by Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hyper

Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

370 pages • missing pub info (view editions)

nonfiction health informative medium-paced
Powered by AI (Beta)
Loading...

Description

Almost 75 million American adults-approximately one-third-have hypertension. The prevalence of hypertension increases with advancing age such that more than half of people 55 to 74 years old and approximately three-fourths of those age 75 years an...

Read more

Community Reviews

Loading...

Content Warnings

Loading...